Where is the optimal plane to mobilize the anterior rectal wall in female patients undergoing total mesorectal excision?

Table 1 General information of the patient

	Control group (n = 42)	Experimental group (n = 35)	P value
Height, mean (SD), cm	157.64 (6.03)	157.17 (5.29)	0.72
Weight, mean (SD), kg	57.02 (8.82)	57.37 (10.22)	0.87
BSA, mean (SD)	1.62 (0.14)	1.67 (0.15)	0.17
Age, mean (SD), y	60.50 (10.94)	63.86 (12.77)	0.22
Preoperative chemoradiotherapy	6 (14.3)	4 (11.4)	0.98

BSA: Body surface area.

Table 2 Postoperative information of the patient

	Control group (n = 42)	Experimental group (n = 35)	P value
Operation time, mean (SD), min	233.14 (75.12)	228.66 (80.32)	0.8
IB, median (IQR), mL	22.5 (19.5-50)	17 (5-20)	0.01
NRL, median (IQR)	13.5 (10-16.5)	15 (13-19)	0.24
Hospital stays, median (IQR), days	9 (7-11.25)	7 (6-10)	0.03
Pathology stage			0.52
I	21 (50.0)	15 (42.8)
II	10 (23.8)	9 (25.7)
III	11 (26.2)	11 (31.5)
T			0.62
1	12 (28.6)	8 (22.9)
2	12 (28.6)	12 (34.3)
3	15 (35.7)	10 (28.6)
4	3 (7.1)	5 (14.3)
N			0.75
0	32 (76.2)	24 (68.6)
1	8 (19.0)	9 (25.7)
2	2 (4.8)	2 (5.7)
CDC			0.84
I	8 (19.0)	3 (8.6)
II	2 (4.8)	1 (2.9)
Postoperative complications	10 (23.81)	4 (11.43)	0.16
Postoperative bleeding	1	0
Anastomotic leakage	3	2
Other complications	8	4

CDC: Clavien-Dindo classification; IB: Intraoperative bleeding; IQR: Inter-quartile range; NRL: Number of retrieved lymph nodes.